Clinical Trial

PK and Relative Bioavailability of Novel Liquid Metformin vs Tablets

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 23, 2025 (before its estimated June 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is an open-label, randomized, three-period crossover study evaluating the single-dose pharmacokinetics and relative bioavailability of a novel liquid metformin formulation at concentrations of 100 mg/mL and 250 mg/mL compared with immediate-release metformin tablets in healthy adult subjects. All participants will receive each formulation in randomized sequence with washout periods between treatments. Serial blood samples will be collected to characterize metformin pharmacokinetic parameters, and safety and tolerability will be assessed throughout the study.
Trial Details
NCT Number NCT07300020
Lead Sponsor Aspargo Labs, Inc
Conditions Healthy Volunteer
Enrollment 24 participants
Start Date 2026-04-15
Primary Completion 2026-06-15 (estimated)
Study Completion 2026-06-28 (estimated)
Updated on ClinicalTrials.gov 2025-12-23